Skip to content
Sunday, March 7, 2021
Latest:
  • Common myths and truths about lymphedema
  • Pandemic, power outages, and…policy on child poverty?
  • Proteomics analysis identifies potential drug targets for aggressive human cancers
  • Resonance podcast: Clinical education and the art of ballroom dancing
  • Image of the Month: The laboratory worm, C. elegans

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Blog Network
  • Momentum
    • About Momentum
    • Contributors
      • Dana Benson
      • Nicole Blanton
      • Molly Chiu
      • Kaylee Dusang
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Resources
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Connect With Us
  • bcm.edu

neuroblastoma

From The Labs 

CAR NKT cells, a promising step forward in the treatment of solid tumors

November 10, 2020November 10, 2020 Ana Rodríguez 0 Comments CAR NK T cells, clinical trial, Immunotherapy, neuroblastoma, Research, solid tumors

An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.

Read more
From The Labs 

Understanding the cancer risk in children with birth defects

June 25, 2020June 25, 2020 Ana Rodríguez 0 Comments ALL, Birth defects, cancer risk, hepatoblastoma, neuroblastoma, pediatric oncology, Research

Understanding the cancer risk in children with birth defects has been a challenge. Although scientific studies suggest that birth defects increase the risk of cancer,

Read more
From The Labs 

From the labs to bedside: First-in-human trial shows promise in treating neuroblastoma

May 28, 2019May 28, 2019 Ana Rodríguez 0 Comments chimeric antigen, Clinical Trials, GD2, GD2-CAR, Immunotherapy, neuroblastoma, Research

Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs features an image of the laboratory worm, Caenorhabditis elegans. Image credit: Dr. Tao Chen/Wang lab.

Healthy Habits: A DOC-umentary Series

https://youtu.be/MAXO08xs9fc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951